JPMorgan raised the firm’s price target on GSK to 1,660 GBp from 1,530 GBp and keeps an Underweight rating on the shares. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today’s best-performing stocks on TipRanks >> Read More on GSK: GSK Forecasts a Year of Strong Growth GSK Pharma put volume heavy and directionally bearish GSK Updates Share Capital and Voting Rights GSK raises 2024 core EPS growth view to 8%-10% from 6%-9% GSK reports Q1 core EPS 43.1p, up 28% at CER